Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma


The inhaled corticosteroid fluticasone furoate (FF) and the long-acting β₂ agonist vilanterol (VI) are in development as a combined once-daily therapy for asthma and chronic obstructive pulmonary disease. Our study objectives were to compare the efficacy and safety of once-daily FF/VI with FF alone and twice-daily fluticasone propionate (FP) in patients aged ≥12 years with moderate-to-severe persistent asthma. Patients (n=586) received FF/VI 200/25 μg or FF 200 μg once-daily (evening dosing), or FP 500 μg twice-daily for 24 weeks. Co-primary end-points were change from baseline in trough forced expiratory volume in 1 s (FEV₁) weighted mean (wm) 0-24 h serial FEV1. Secondary end-points included change from baseline in percentage of rescue-free 24-h periods, percentage of symptom-free 24-h periods and total Asthma Quality of Life Questionnaire (AQLQ). Safety assessments included adverse events, 24-h urinary cortisol excretion, vital signs and ECG. FF/VI significantly improved trough FEV1 and wmFEV₁ versus FF and FP. Significantly more rescue-free and symptom-free 24-h periods were reported with FF/VI versus FF. Treatment differences for AQLQ were not significant. Incidence of adverse events was similar across groups. No clinically significant differences were seen for 24-h urinary cortisol excretion, vital signs or ECG. FF/VI resulted in statistically greater improvements in lung function and symptomatic end-points versus FF, and was well tolerated in this asthma population.

DOI: 10.1183/09031936.00064513

Extracted Key Phrases

7 Figures and Tables

Citations per Year

131 Citations

Semantic Scholar estimates that this publication has 131 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{OByrne2014OncedailyFF, title={Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma}, author={Paul Matthew O’Byrne and Eugene Bleecker and Eric D Bateman and William W. Busse and Ashley Woodcock and Richard Forth and William T. Toler and Loretta Jacques and Jan L{\"{o}tvall}, booktitle={The European respiratory journal}, year={2014} }